- Location
Drug Resistant Tuberculosis
"-
This Unmet Need Is Mapped for The First Time
Feb 8, 2014Only 1 in 10 people who need palliative care - that is medical care to relieve the pain, symptoms and stress of serious illness - is currently receiving it. This unmet need is mapped for the first time in the "Global atlas of palliative ...
Tags: WPCA, HIV, drug-resistant tuberculosis, health-care systems
-
A Patient's Bone Marrow Stem Cells Might Be Used to Treat Multidrug-Resistant Tuberculosis
Jan 13, 2014A patient's own bone marrow stem cells might someday be used to treat multidrug-resistant tuberculosis, a new study suggests. The phase 1 study to assess the safety of the treatment included 30 patients, aged 21 to 65, with ...
-
Janssen Therapeutics Has Obtained Accelerated Approval From FDA for Sirturo Tablets
Jan 4, 2013Janssen Therapeutics has obtained accelerated approval from FDA for Sirturo (bedaquiline) tablets as part of combination therapy to treat adult patients with pulmonary multi-drug resistant tuberculosis (MDR-TB). The surrogate endpoint of ...
Tags: Janssen Therapeutics, accelerated approval, FDA, Sirturo tablets
-
Janssen-Cilag International Submitted a Marketing Authorisation Application
Dec 5, 2012Janssen-Cilag International has submitted a Marketing Authorisation Application to the European Medicines Agency (EMA) seeking conditional approval to use the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as ...
Tags: investigational drug bedaquiline, multi-drug resistant tuberculosis
-
Janssen Submits Bedaquiline (TMC207) New Drug Application (Nda) to FDA for Approval.
Dec 4, 2012Janssen Research & Development company has submitted bedaquiline (TMC207) new drug application (NDA) to the US Food and Drug Administration (FDA) for approval. Bedaquiline,an investigational drug administered orally,is used as part of ...
Tags: FDA, new drug application, investigational drug, pulmonary
